What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 May 2024
Historique:
medline: 18 5 2024
pubmed: 18 5 2024
entrez: 17 5 2024
Statut: epublish

Résumé

The aim of this study was to map and compare stakeholders' perceptions of barriers towards cervical cancer screening for vulnerable women in seven European countries. In Collaborative User Boards, stakeholders were invited to participate to identify barriers towards participation in cervical cancer screening. The study is nested in the European Union-funded project CBIG-SCREEN which aims to tackle inequity in cervical cancer screening for vulnerable women (www.cbig-screen.eu). Data collection took place in Bulgaria, Denmark, Estonia, France, Italy, Portugal and Romania. Participants represented micro-level stakeholders covering representatives of users, that is, vulnerable women, meso-level stakeholders covering healthcare professionals and social workers, and macro-level stakeholders covering programme managers and decision-makers. Across the seven countries, 25 meetings in Collaborative User Boards with a duration of 2 hours took place between October 2021 and June 2022. The meetings were video recorded or audio recorded, transcribed and translated into English for a qualitative framework analysis. 120 participants took part in the Collaborative User Boards. Context-specific barriers were related to different healthcare systems and characteristics of vulnerable populations. In Romania and Bulgaria, the lack of a continuous screening effort and lack of ways to identify eligible women were identified as barriers for all women rather than being specific for women in vulnerable situations. The participants in Denmark, Estonia, France, Italy and Portugal identified providers' lack of cultural and social sensitivity towards vulnerable women as barriers. In all countries, vulnerable women's fear, shame and lack of priority to preventive healthcare were identified as psychological barriers. The study provides an overview of stakeholders' perceived barriers towards vulnerable women's cervical cancer screening participation in seven European countries. The organisation of healthcare systems and the maturity of screening programmes differ between countries, while vulnerable women's psychological barriers had several similarities.

Identifiants

pubmed: 38760040
pii: bmjopen-2023-079921
doi: 10.1136/bmjopen-2023-079921
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e079921

Investigateurs

Marc Bardou (M)
Berit Andersen (B)
Pia Kirkegaard (P)
Rikke Buus Bøje (RB)
Mette Tranberg (M)
Rosa Legood (R)
Anna Foss (A)
Martin McKee (M)
Rachel Greenley (R)
Luke Vale (L)
Li Sun (L)
Sadie Bell (S)
Paolo Giorgi Rossi (PG)
Luca Ghirotto (L)
Letizia Bartolini (L)
Giusy Iorio (G)
Laura Bonvicini (L)
Noemi Auzzi (N)
Paola Mantellini (P)
Nuno Lunet (N)
João Firmino-Machado (J)
Ana Fernandes (A)
Margarida Teixeira (M)
Firmino Machado (F)
Mariana Amorim (M)
Inês Baía (I)
Romeu Mendes (R)
Cláudia Gouvinhas (C)
Anneli Uusküla (A)
Anna Tisler (A)
Adriana Baban (A)
Diana Tăut (D)
Nicoleta Jiboc (N)
Florian Nicula (F)
Alexandra Tolnai (A)
Rebecca Moore (R)
Vanessa Moore (V)
Partha Basu (P)
Isabel Mosquera Metcalfe (IM)
Keitly Mensah (K)
Eric Lucas (E)
Lise Rochaix (L)
Camilla Fiorina (C)
Violette Delisle (V)
Irina Todorova (I)
Yulia Panayotova (Y)
Tatyana Kotzeva (T)
Raya Mihaylova (R)
David Ritchie (D)
Helena Ros Comesana (HR)
Meritxel Mallafré-Larrosa (M)
Ginevra Papi (G)
Wendy Yared (W)
Arianna Khatchadourian (A)
Christiane Dascher-Nade (C)

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Rikke Buus Bøje (RB)

University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark rikkbj@rm.dk.

Marc Bardou (M)

CIC-P INSERM 1432, Institut national de la santé et de la recherche médicale, Paris, France.

Keitly Mensah (K)

Early Detection, Prevention and Infections Branch, IARC, Lyon, France.

Raquel Rico Berrocal (R)

Centre d'Etudes des Mouvements Sociaux, Ecole des Hautes Etudes en Sciences Sociales, Paris, France.

Paolo Giorgi Rossi (P)

Servizio Interaziendale Epidemiologia, Azienda Unita Sanitaria Locale della Romagna, Ravenna, Italy.

Laura Bonvicini (L)

Servizio Interaziendale Epidemiologia, Azienda Unita Sanitaria Locale della Romagna, Ravenna, Italy.

Noemi Auzzi (N)

Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Osservatorio Nazionale Screening, Florence, Italy.

Diana Taut (D)

Babes-Bolyai University, Cluj-Napoca, Romania.

Nicoleta Jiboc (N)

Babes-Bolyai University, Cluj-Napoca, Romania.

Anna Tisler (A)

Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.

Kerli Reintamm (K)

Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.

Anneli Uusküla (A)

University of Tartu, Tartu, Estonia.

Margarida Teixeira (M)

EPI Unit-Institute of Public Health, University of Porto, Porto, Portugal.

João Firmino-Machado (J)

EPI Unit-Institute of Public Health, University of Porto, Porto, Portugal.

Mariana Amorim (M)

EPI Unit-Institute of Public Health, University of Porto, Porto, Portugal.

Ines Baia (I)

EPI Unit-Institute of Public Health, University of Porto, Porto, Portugal.

Nuno Lunet (N)

EPI Unit-Institute of Public Health, University of Porto, Porto, Portugal.

Raya Michaylova (R)

Health Psychology Research Center, Sofia, Bulgaria.

Yulia Panayotova (Y)

Health Psychology Research Center, Sofia, Bulgaria.

Tatyana Kotzeva (T)

Health Psychology Research Center, Sofia, Bulgaria.

Berit Andersen (B)

University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Pia Kirkegaard (P)

University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH